Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed c...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Interdisciplinary Perspectives on Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2009/214216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559339305435136 |
---|---|
author | U. R. Goonetilleke S. A. Ward S. B. Gordon |
author_facet | U. R. Goonetilleke S. A. Ward S. B. Gordon |
author_sort | U. R. Goonetilleke |
collection | DOAJ |
description | Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed countries, approximately half of the survivors suffer intellectual impairment, hearing loss, or other neurological damage. There is an urgent need for more information about the mechanisms of brain damage and death in pneumococcal meningitis so that new treatments can be designed. Using proteomic techniques and bioinformatics, the protein content of cerebrospinal fluid can be examined in great detail. Animal models have added greatly to our knowledge of possible mechanisms and shown that hippocampal apoptosis and cortical necrosis are distinct mechanisms of neuronal death. The contribution of these pathways to human disease is unknown. Using proteomic techniques, neuronal death pathways could be described in CSF samples. This information could lead to the design of novel therapies to minimize brain damage and lower mortality. This minireview will summarize the known pathogenesis of meningitis, and current gaps in knowledge, that could be filled by proteomic analysis. |
format | Article |
id | doaj-art-347b9b225b9d4e7d9727992b3b44df4c |
institution | Kabale University |
issn | 1687-708X 1687-7098 |
language | English |
publishDate | 2009-01-01 |
publisher | Wiley |
record_format | Article |
series | Interdisciplinary Perspectives on Infectious Diseases |
spelling | doaj-art-347b9b225b9d4e7d9727992b3b44df4c2025-02-03T01:30:14ZengWileyInterdisciplinary Perspectives on Infectious Diseases1687-708X1687-70982009-01-01200910.1155/2009/214216214216Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?U. R. Goonetilleke0S. A. Ward1S. B. Gordon2Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKMolecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKPulmonary Immunology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKStreptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed countries, approximately half of the survivors suffer intellectual impairment, hearing loss, or other neurological damage. There is an urgent need for more information about the mechanisms of brain damage and death in pneumococcal meningitis so that new treatments can be designed. Using proteomic techniques and bioinformatics, the protein content of cerebrospinal fluid can be examined in great detail. Animal models have added greatly to our knowledge of possible mechanisms and shown that hippocampal apoptosis and cortical necrosis are distinct mechanisms of neuronal death. The contribution of these pathways to human disease is unknown. Using proteomic techniques, neuronal death pathways could be described in CSF samples. This information could lead to the design of novel therapies to minimize brain damage and lower mortality. This minireview will summarize the known pathogenesis of meningitis, and current gaps in knowledge, that could be filled by proteomic analysis.http://dx.doi.org/10.1155/2009/214216 |
spellingShingle | U. R. Goonetilleke S. A. Ward S. B. Gordon Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? Interdisciplinary Perspectives on Infectious Diseases |
title | Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? |
title_full | Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? |
title_fullStr | Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? |
title_full_unstemmed | Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? |
title_short | Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis? |
title_sort | could proteomic research deliver the next generation of treatments for pneumococcal meningitis |
url | http://dx.doi.org/10.1155/2009/214216 |
work_keys_str_mv | AT urgoonetilleke couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis AT saward couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis AT sbgordon couldproteomicresearchdeliverthenextgenerationoftreatmentsforpneumococcalmeningitis |